Skip to main content
. Author manuscript; available in PMC: 2010 Jan 25.
Published in final edited form as: Am J Geriatr Psychiatry. 2003 Nov–Dec;11(6):667–673. doi: 10.1176/appi.ajgp.11.6.667

TABLE 3.

Cognitive decline (change scores) within and between the two groups

APOE ε4 Carriers (N=20) APOE ε4 Within-Group (t[df]; p) Non-APOE ε4 Carriers (N=29) Non-APOE ε4 Within-Group (t[df]; p) Between-Group (t[df]; p)
BFR −14.4 (18.9)** −3.4[19]; 0.003 −4.2 (12.5) −1.8[28]; 0.08 2.1[47]; 0.03*
Rey copy −1.9 (4.9)** −3.3[19]; 0.004 −2.9 (5.1)** −3.6[28]; 0.001 −0.7[47]; 0.5
Rey delayed recall −2.2 (3.1) −1.7[19]; 0.1 −2.4 (3.6)** −3.1[28]; 0.005 −0.16[47]; 0.9
CFL 1.3 (9.4) 0.6[19]; 0.5 2.0 (8.1) 1.3[28]; 0.18 0.29[47]; 0.8
BNT −2.2 (8.3) −1.2[19]; 0.2 −0.7 (1.5)* −2.3[28]; 0.03 0.8[19.9]; 0.4

Note: Values are mean (standard deviation), unless otherwise indicated.

BFR: Buschke-Fuld Selective Reminding, Total Score, a measure of verbal memory;30 Rey copy: Rey-Osterrieth Complex Figure, Copy, a measure of visuospatial functioning;31 Rey delayed: Rey-Osterrieth Complex Figure, Delayed Recall,31 a measure of nonverbal memory; CFL: test of verbal fluency;32 BNT: Boston Naming Test, a measure of naming.33

*

p<0.05 within-or between-group comparisons in the test change scores;

**

p<0.01 within-or between-group comparisons in the test change scores.